Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$7.48B
sum of reported positions
Reported positions
301
Changes vs prior quarter
296
60 new · 37 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 314 measured positions in 8 quarters, the typical new or larger position finished −0.9 pts against the S&P 500 and 47% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 1.96M | $294M | 3.9% | |
| 673K | $292M | 3.9% | |
| 2.15M | $208M | 2.8% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $6.05B | $7.48B |
| Positions | 278 | 301 |
| Biggest line | — | Guardant Health 4% |
| 415K |
| $203M |
| 2.7% |
| 1.25M | $146M | 2.0% |
| 68K | $136M | 1.8% |
| 491K | $132M | 1.8% |
| 599K | $130M | 1.7% |
| 107K | $125M | 1.7% |
| 103K | $117M | 1.6% |
| 126K | $117M | 1.6% |
| 2.11M | $116M | 1.6% |
| 880K | $105M | 1.4% |
| 339K | $101M | 1.3% |
| 6.25M | $98.1M | 1.3% |
| 611K | $93.5M | 1.2% |
| 536K | $90.6M | 1.2% |
| 307K | $89.8M | 1.2% |
| 342K | $89M | 1.2% |
| 252K | $85.7M | 1.1% |
| 728K | $83.9M | 1.1% |
| 1.38M | $80.2M | 1.1% |
| 58K | $79.7M | 1.1% |
| 499K | $79.4M | 1.1% |
| 186K | $79.3M | 1.1% |
Guardant Health (GH)
2.36M → 1.96M shares (−17%)
Lam Research (LRCX)
688K → 673K shares (−2%)
Xometry (XMTR)
2.96M → 2.15M shares (−27%)
Trane Technologies (TT)
407K → 415K shares (+2%)
Mirum Pharmaceuticals (MIRM)
1.41M → 1.25M shares (−11%)
Targa Resources (TRGP)
502K → 491K shares (−2%)
Old Dominion (ODFL)
592K → 599K shares (+1%)
GE Vernova (GEV)
133K → 107K shares (−20%)
United Rentals (URI)
98K → 103K shares (+6%)
Scholar Rock Holding (SRRK)
2.2M → 2.11M shares (−4%)
Irhythm Holdings (IRTC)
761K → 880K shares (+16%)
KLA Corporation (KLAC)
40K → 339K shares (+756%)
Beta Bionics (BBNX)
5.95M → 6.25M shares (+5%)
nVent Electric (NVT)
524K → 536K shares (+2%)
Datadog (DDOG)
240K → 342K shares (+43%)
Entergy (ETR)
683K → 728K shares (+7%)
Vistra Corp. (VST)
493K → 499K shares (+1%)
Dell Technologies (DELL)
97K → 186K shares (+91%)
Royalty Pharma (RPRX)
1.31M → 1.38M shares (+5%)
Axsome Therapeutics (AXSM)
520K → 317K shares (−39%)
Teradyne (TER)
127K → 148K shares (+16%)
D. R. Horton (DHI)
431K → 437K shares (+1%)
Quanta Services (PWR)
89K → 93K shares (+4%)
Williams Companies (WMB)
832K → 898K shares (+8%)
Mettler Toledo (MTD)
51K → 52K shares (+3%)
